Neuronetics Q3 revenue beats estimates on greenbrook growth

What happened

Neuronetics said third-quarter revenue rose 12.5% and beat analyst expectations, driven by higher revenue from Greenbrook. The company reported a narrower net loss than a year earlier and said gross margin, the share of revenue remaining after direct costs, improved to 52.2%.

Confirmed

Global impact / market context

Higher Greenbrook revenue helped lift sales, while improved revenue cycle management, meaning how the company bills and collects payments, helped raise gross margin. Lower sales and marketing costs also reduced operating expenses, supporting the path toward better financial performance.

Analyst inference

The quarterly growth and improved gross margin suggest stronger sales and cost control, but the outlook gives investors a benchmark to judge execution. Revenue falling short of expectations or spending rising could weaken cash available, while sustained growth could support the company’s ability to fund operations.

Analyst inference

What to watch

1. Check whether Greenbrook continues to add revenue in coming quarters, because the company identified its higher revenue as the driver of overall third-quarter growth. Analyst inference
2. Compare reported gross margin with the company’s 2026 target range; consistency would suggest the sales approach and payment collection are helping control direct costs. Analyst inference
3. Watch whether reduced sales and marketing expenses continue to hold down operating costs, since the company lowered its full-year spending forecast. Analyst inference

Evidence

• Original source link unavailable